NCT03341936 Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03340532 HealthSmart: Promoting Healthy Lifestyles for Young Adult Cancer Survivors Using Educational Videos Status COMPLETED Phase NA
NCT03333616 Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03328091 Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen) Status COMPLETED Phase NA
NCT03319901 Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL Status RECRUITING Phase PHASE1/PHASE2
NCT03316599 Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT03316586 A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer Status COMPLETED Phase PHASE2
NCT03310879 Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6 Status RECRUITING Phase PHASE2
NCT03304756 Study of Neoadjuvant Treatment of Locally Advanced Breast Cancer With CAP Regimen Status COMPLETED Phase PHASE2
NCT03291951 FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study Status COMPLETED Phase NA
NCT03291730 A Nurse Led Project to Introduce Hand Lettering as a Form of Creative Art Expression to Patients in an Ambulatory Oncology Setting Status COMPLETED Phase NA
NCT03289676 Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV Status COMPLETED Phase PHASE1
NCT03289039 Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT03279055 Web-based Insomnia Treatment for Adolescent and Young Adult Cancer Survivors Status COMPLETED Phase NA
NCT03277482 Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer Status TERMINATED Phase PHASE1